|
VMD
|
What Glen is saying (correctly or not) is that there was a test group, and of...
|
|
VMD
|
I agree, but I contacted PR with no success - see blow: No. 53 percent...
|
|
T.III
|
The outside closing date is mid-August 2019, which coincides with the Q2...
|
|
HSDT
|
I am getting the sense that management is treating us shareholders like...
|
|
HSDT
|
If you are referring to today's News Release, it is astonishing that EEG&...
|
|
HSDT
|
Thanks prokofiev! But, as a layman, I am still puzzled by the FDA denial? My...
|
|
TRQ
|
TRQ traded about 64 million shares today (most recently about 4 or 5 million...
|
|
TRQ
|
The Working Group Report was submitted to Parliament on 03/22/19. OT received...
|
|
TRQ
|
I have just started to take an interest in TRQ, so my take, for what it's...
|
|
TRQ
|
https://www.argusresearch.com/pdfdownload.aspx?id...
|
|
HSDT
|
prokofiev, you are a knowledgeable person and appear to have some connection...
|
|
HSDT
|
steelinvestor, I am also concerned that management did not spell out...
|
|
HSDT
|
The FDA discussion during the conference call was inadequate - no new...
|
|
HSDT
|
Management was very confident that the FDA would approve (shortly before FDA...
|
|
HSDT
|
Management is deficient in its communications with its investors: We...
|
|
HSDT
|
Mike, I fear that you are very confused. On April 5, 2019, Deschamps...
|
|
HSDT
|
https://www.lifemark.ca/document/brainport_balance_plus_device_info_all_in...
|
|
HSDT
|
Thanks - interesting analysis. However, I don't think that it addresses...
|
|
HSDT
|
On reflection, the Oppenheimer analyst obviously expected FDA approval in...
|
|
HSDT
|
Well, the Oppenheiner analyst predicted no FDA approval in 2019 - well done...
|